Education
School ¡X Major ¡X Degree | Duration |
---|---|
°ª¶¯Âå¾Ç¤j¾Ç ¡X ÃľǨt(²¦) ¡X ³Õ¤h Doctorate, School of Pharmacy, Kaohsiung Medical University |
2002/09 ¡X 2008/06 |
°ª¶¯Âå¾Ç¤j¾Ç ¡X ¤ÑµMÃĪ«¬ã¨s©Ò(²¦) ¡X ºÓ¤h Master, Graduate Institute of Natural Products, Kaohsiung Medical University |
2000/09 ¡X 2002/06 |
¹Å«nÃľDZM¬ì¾Ç®Õ ¡X ÃľǬì(²¦) ¡X ¤±M Five-year college, Department of Pharmacy, Chia Nan University of Pharmacy ¡® Science |
1989/09 ¡X 1995/06 |
Intramural Experience
Office/Department/Institute | Position | Duration |
---|---|---|
ÃľǬì Pharmacy Division | Pharmacist | ¡X |
ÃľǨt School of Pharmacy | Professor | 2023/08/01 ¡X |
»ùÛ«~¾Ç¨t Department of Fragrance and Cosmetic Science | Professor | 2021/08/01 ¡X 2023/07/31 |
ÃľǨt School of Pharmacy | Professor | 2020/02/01 ¡X 2021/07/31 |
ÃľǨt School of Pharmacy | Associate Professor | 2016/03/01 ¡X 2020/01/31 |
ÃľǨt School of Pharmacy | Assistant Professor | 2013/02/01 ¡X 2016/02/29 |
Extramural Experience
Discipline
NO | Discipline | Expertise |
---|---|---|
1 | ¥Íª«Âå¹AÃþ Biology, Medicine and Agriculture | ÃľǤΤ¤ÂåÃÄ Pharmacy and Chinese Medicine and Pharmacy |
2 | ¦ÛµM¬ì¾ÇÃþ Natural Sciences | ¤Æ¾Ç Chemistry |
Research & Technology Platform Open to the Outside
Interested Area(s)for Interdisciplinary Research
¤p¤À¤l¤Æ¦Xª«¬¡©Ê¿z¿ï»P±´°Q¤À¤lÃIJz¬¡©Ê¾÷Âà
compounds with specific activity on a screening assay and molecular mechanism of action
Area(s) of Expertise & Research
¦³¾÷¦X¦¨,ÃĪ«¤Æ¾Ç,ÃĪ«³]p,¤Æ¦Xª«§ÜÀù¬¡©Êµû¦ô
organic synthesis, medicinal chemistry, drug design, anticancer assay
Publication
NO | Publication |
---|---|
1 | Skin delivery of synthetic benzoyl pterostilbenes suppresses atopic dermatitis-like inflammation through the inhibition of keratinocyte and macrophage activation. Skin delivery of synthetic benzoyl pterostilbenes suppresses atopic dermatitis-like inflammation through the inhibition of keratinocyte and macrophage activation. |
2 | ¦X¦¨»P§ÜÀùµû¦ô4-Anilinoquinolinylchalcone Synthesis and Anticancer Evaluation of 4-Anilinoquinolinylchalcone Derivatives |
3 | Myricetin Nanofibers Enhanced Water Solubility and Skin Penetration for Increasing Antioxidant and Photoprotective Activities. Myricetin Nanofibers Enhanced Water Solubility and Skin Penetration for Increasing Antioxidant and Photoprotective Activities. |
4 | Determination of the Bacterial Community of Mustard Pickle Products and Their Microbial and Chemical Qualities. Determination of the Bacterial Community of Mustard Pickle Products and Their Microbial and Chemical Qualities. |
5 | Skin delivery of synthetic benzoyl pterostilbenes suppresses atopic dermatitis-like inflammation through the inhibition of keratinocyte and macrophage activation. Skin delivery of synthetic benzoyl pterostilbenes suppresses atopic dermatitis-like inflammation through the inhibition of keratinocyte and macrophage activation. |
6 | A novel quinoline derivative, DFIQ, sensitizes NSCLC cells to ferroptosis by promoting oxidative stress accompanied by autophagic dysfunction and mitochondrial damage. A novel quinoline derivative, DFIQ, sensitizes NSCLC cells to ferroptosis by promoting oxidative stress accompanied by autophagic dysfunction and mitochondrial damage. |
7 | Inhibition of gut microbial £]-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis. Inhibition of gut microbial £]-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis. |
8 | Effect of High-Pressure Treatment on Blue Marlin (Makaira nigricans) Quality During Storage Effect of High-Pressure Treatment on Blue Marlin (Makaira nigricans) Quality During Storage |
9 | Effects of high-hydrostatic-pressure processing on the chemical and microbiological quality of raw ready-to-eat hard clam marinated in soy sauce during cold storage Effects of high-hydrostatic-pressure processing on the chemical and microbiological quality of raw ready-to-eat hard clam marinated in soy sauce during cold storage |
10 | The effectiveness of synthetic methoxylated isoflavones in delivering to the skin and alleviating psoriasiform lesions via topical absorption The effectiveness of synthetic methoxylated isoflavones in delivering to the skin and alleviating psoriasiform lesions via topical absorption |
11 | Inhibitory Effects of High-Hydrostatic-Pressure Processing on Growth and Histamine Formation of Histamine-Forming Bacteria in Yellowfin Tuna Meat during Storage Inhibitory Effects of High-Hydrostatic-Pressure Processing on Growth and Histamine Formation of Histamine-Forming Bacteria in Yellowfin Tuna Meat during Storage |
12 | Quality Improvement in Mackerel Fillets Caused by Brine Salting Combined with High-Pressure Processing Quality Improvement in Mackerel Fillets Caused by Brine Salting Combined with High-Pressure Processing |
13 | Antioxidant, Anti-Inflammation and Antiaging Activities of Artocarpus altilis Methanolic Extract on Urban Particulate Matter-Induced HaCaT Keratinocytes Damage Antioxidant, Anti-Inflammation and Antiaging Activities of Artocarpus altilis Methanolic Extract on Urban Particulate Matter-Induced HaCaT Keratinocytes Damage |
14 | µo²{¤TÐü¨F§Q«×Óil¥Íª«§@¬°§ÜÅÖºû¤ÆÃľ¯ Discovery of triazolyl thalidomide derivatives as anti-fibrosis agents |
15 | Discovery of an Orally Efficacious MYC Inhibitor for Liver Cancer Using a GNMT-Based High-Throughput Screening System and Structure-Activity Relationship Analysis. Discovery of an Orally Efficacious MYC Inhibitor for Liver Cancer Using a GNMT-Based High-Throughput Screening System and Structure-Activity Relationship Analysis. |
16 | Enhancement of Anticancer Potential of Pterostilbene Derivative by Chalcone Hybridization Enhancement of Anticancer Potential of Pterostilbene Derivative by Chalcone Hybridization |
17 | Topical Artocarpus communis Nanoparticles Improved the Water Solubility and Skin Permeation of Raw A. communis Extract, Improving Its Photoprotective Effect Topical Artocarpus communis Nanoparticles Improved the Water Solubility and Skin Permeation of Raw A. communis Extract, Improving Its Photoprotective Effect |
18 | Pterostilbene Attenuates Particulate Matter-Induced Oxidative Stress, Inflammation and Aging in Keratinocytes Pterostilbene Attenuates Particulate Matter-Induced Oxidative Stress, Inflammation and Aging in Keratinocytes |
19 | Synthetic Naphthofuranquinone Derivatives Are Effective in Eliminating Drug-Resistant Candida albicans in Hyphal, Biofilm, and Intracellular Forms: An Application for Skin-Infection Treatment Synthetic Naphthofuranquinone Derivatives Are Effective in Eliminating Drug-Resistant Candida albicans in Hyphal, Biofilm, and Intracellular Forms: An Application for Skin-Infection Treatment |
20 | Facile skin targeting of a thalidomide analog containing benzyl chloride moiety alleviates experimental psoriasis via the suppression of MAPK/NF-£eB/AP-1 phosphorylation in keratinocytes Facile skin targeting of a thalidomide analog containing benzyl chloride moiety alleviates experimental psoriasis via the suppression of MAPK/NF-£eB/AP-1 phosphorylation in keratinocytes |
21 | Discovery of 4-Anilinoquinolinylchalcone Derivatives as Potential NRF2 Activators. Discovery of 4-Anilinoquinolinylchalcone Derivatives as Potential NRF2 Activators. |
22 | Pharmacological inhibition of bacterial £]-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo Pharmacological inhibition of bacterial £]-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo |
23 | Phytochemical Naphtho[1,2-b] furan-4,5-dione Induced Topoisomerase II-mediated DNA Damage Response in Human Non-small-Cell Lung Cancer Phytochemical naphtho[1,2-b] furan-4,5‑dione induced topoisomerase II-mediated DNA damage response in human non-small-cell lung cancer. |
24 | Liposomal Avicequinone-B formulations: Aqueous solubility, physicochemical properties and apoptotic effects on cutaneous squamous cell carcinoma cells Liposomal Avicequinone-B formulations: Aqueous solubility, physicochemical properties and apoptotic effects on cutaneous squamous cell carcinoma cells |
25 | Discovery of Furanoquinone Derivatives as a Novel Class of DNA Polymerase and Gyrase Inhibitors for MRSA Eradication in Cutaneous Infection Discovery of Furanoquinone Derivatives as a Novel Class of DNA Polymerase and Gyrase Inhibitors for MRSA Eradication in Cutaneous Infection |
26 | Improvement of skin penetration, antipollutant activity and skin hydration of 7,3¡¬,4¡¬- trihydroxyisoflavone cyclodextrin inclusion complex Improvement of skin penetration, antipollutant activity and skin hydration of 7,3¡¬,4¡¬- trihydroxyisoflavone cyclodextrin inclusion complex |
27 | Design, synthesis, and anti-bacterial evaluation of triazolyl-pterostilbene derivatives Design, synthesis, and anti-bacterial evaluation of triazolyl-pterostilbene derivatives |
28 | Discovery of 3-Arylquinoxaline Derivatives as Potential Anti-Dengue Virus Agents Discovery of 3-Arylquinoxaline Derivatives as Potential Anti-Dengue Virus Agents |
29 | Discovery of 2-Substituted 3-Arylquinoline Derivatives as Potential Anti-Inflammatory Agents Through Inhibition of LPS-Induced Inflammatory Responses in Macrophages. Discovery of 2-Substituted 3-Arylquinoline Derivatives as Potential Anti-Inflammatory Agents Through Inhibition of LPS-Induced Inflammatory Responses in Macrophages. |
30 | Discovery of naphtho[1,2-d]oxazole derivatives as potential anti-HCV agents through inducing heme oxygenase-1 expression Discovery of naphtho[1,2-d]oxazole derivatives as potential anti-HCV agents through inducing heme oxygenase-1 expression |
31 | Discovery of pyrazolo[4,3-c]quinolines derivatives as potential anti-inflammatory agents through inhibiting of NO production Discovery of pyrazolo[4,3-c]quinolines derivatives as potential anti-inflammatory agents through inhibiting of NO production |
32 | Synthesis and Biological Evaluation of Thalidomide Derivatives as Potential Anti-Psoriasis Agents Synthesis and Biological Evaluation of Thalidomide Derivatives as Potential Anti-Psoriasis Agents |
33 | Discovery of 3-amino-2-hydroxypropoxyisoflavone derivatives as potential anti-HCV agents Discovery of 3-amino-2-hydroxypropoxyisoflavone derivatives as potential anti-HCV agents |
34 | Preparation, characterizations and anti-pollutant activity of 7,3¡¬,4¡¬-trihydroxyisoflavone nanoparticles in particulate matter- induced HaCaT keratinocytes Preparation, characterizations and anti-pollutant activity of 7,3¡¬,4¡¬-trihydroxyisoflavone nanoparticles in particulate matter- induced HaCaT keratinocytes |
35 | 9-bis[2-(pyrrolidin-1-yl)ethoxy]-6-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}-11H-indeno[1,2-c]quinolin-11-one (BPIQ), a quinoline derivative inhibits human hepatocellular carcinoma cells by inducing ER stress and apoptosis. 9-bis[2-(pyrrolidin-1-yl)ethoxy]-6-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}-11H-indeno[1,2-c]quinolin-11-one (BPIQ), a quinoline derivative inhibits human hepatocellular carcinoma cells by inducing ER stress and apoptosis. |
36 | Dual roles of extracellular signal-regulated kinase (ERK) in quinoline compound BPIQ-induced apoptosis and anti-migration of human non-small cell lung cancer cells. Dual roles of extracellular signal-regulated kinase (ERK) in quinoline compound BPIQ-induced apoptosis and anti-migration of human non-small cell lung cancer cells. |
37 | Discovery of Indeno[1,2-c]quinoline Derivatives as Potent Dual Antituberculosis and Anti-Inflammatory Agents Discovery of Indeno[1,2-c]quinoline Derivatives as Potent Dual Antituberculosis and Anti-Inflammatory Agents |
38 | Naphtho[1,2-b]furan-4,5-dione is a potent anti-MRSA agent against planktonic, biofilm, and intracellular bacteria Naphtho[1,2-b]furan-4,5-dione is a potent anti-MRSA agent against planktonic, biofilm, and intracellular bacteria |
39 | Pterostilbene, a methoxylated resveratrol derivative, efficiently eradicates planktonic, biofilm, and intracellular MRSA by topical application Pterostilbene, a methoxylated resveratrol derivative, efficiently eradicates planktonic, biofilm, and intracellular MRSA by topical application |
40 | Discovery of novel diarylpyrazolylquinoline derivatives as potent anti-dengue virus agents Discovery of novel diarylpyrazolylquinoline derivatives as potent anti-dengue virus agents |
41 | Specific inhibition of bacterial -glucuronidase by pyrazolo[4,3-c]quinoline derivatives via a pH-dependent manner to suppress chemotherapy-induced intestinal toxicity Specific inhibition of bacterial -glucuronidase by pyrazolo[4,3-c]quinoline derivatives via a pH-dependent manner to suppress chemotherapy-induced intestinal toxicity |
42 | ±´¯Áindeno[1,2-b]quinoxaline l¥Íª«¦¨¬°¨ã¦³¼ç¤O¤§§ÜÀùÃľ¯ Discovery of indeno[1,2-b]quinoxaline derivatives as potential anticancer agents |
43 | ¥H»Ä©Ê¨Ì¿à©Ê»E¦Xª«¥]ÂÐ7,3¡¬,4¡¬-trihydroxyisoflavone¤§©`¦ÌÁû²É»s¾¯§@¬°¥~¥Îµ¹ÃĨt²Î Design of acid-responsive polymeric nanoparticles for 7,3¡¬,4¡¬-trihydroxyisoflavone topical administration |
44 | TCH1036, a indeno[1,2-c]quinoline derivative, potentially inhibited the growth of human brain malignant glioma (GBM) 8401 cells via suppression of the expression of Suv39h1 and PARP TCH1036, a indeno[1,2-c]quinoline derivative, potentially inhibited the growth of human brain malignant glioma (GBM) 8401 cells via suppression of the expression of Suv39h1 and PARP |
45 | Quinoline-Based Compound BPIQ Exerts Anti-Proliferative Effects on Human Retinoblastoma Cells via Modulating Intracellular Reactive Oxygen Species Quinoline-Based Compound BPIQ Exerts Anti-Proliferative Effects on Human Retinoblastoma Cells via Modulating Intracellular Reactive Oxygen Species |
46 | ±´¯Á2-[2-(5-nitrofuran-2-yl)vinyl]quinoline ¬°·s«¬§Ü¸~½FÂಾÃľ¯ Discovery of 2-[2-(5-nitrofuran-2-yl)vinyl]quinoline derivatives as a novel type of antimetastatic agents |
47 | ±´¯ÁBenzo[f]indole-4,9-dionel¥Íª«¬°·s«¬§Üµoª¢Ãľ¯ Discovery of Benzo[f]indole-4,9-dione Derivatives as New Types of Anti-Inflammatory Agents |
48 | ±´¯Á·s«¬N-alkyl 4-anilinofuro[2,3-b]quinoline (CIL-102)l¥Íª«¹ï«e¦C¸¢Àù²ÓM¤§§@¥Î Discovery of Novel N-alkyl 4-anilinofuro[2,3-b]quinoline Derivatives (CIL-102 Derivatives) Against Castration-Resistant Human Prostate Cancers |
49 | ±´¯Á3-phenylquinolinylchalconel¥Íª«¨ã¦³¿ï¾Ü©Ê§Ü¨ÅÀù¤§¼ç¤OÃĪ« Discovery of 3-phenylquinolinylchalcone derivatives as potent and selective anticancer agents against breast cancers |
50 | Naphtho[1,2-b]furan-4,5-dioneÂǥѧí¨î Src-mediated «H¸¹³~®|§í¨î MDA-MB-231 ²ÓM¾E²¾©M«Iŧ Naphtho[1,2-b]furan-4,5-dione inhibits MDA-MB-231 cell migration and invasion by suppressing Src-mediated signaling pathways |
51 | ¦X¦¨2-aroyl-3-arylquinolinel¥Íª«¨Ãµû¦ô¨ä§Ü¼W¥Í»P§Üµn²¯f¬r¬¡©Ê Synthesis, antiproliferative and anti-dengue virus evaluations of 2-aroyl-3-arylquinoline derivatives. |
52 | Furano-1,2-Naphthoquinone §í¨î Ca9-22 ¤HÃþ¤fµÄÅìÀù²ÓM¤§Src ©M PI3K/Akt «H¸¹³~®|¡C Furano-1,2-Naphthoquinone Inhibits Src and PI3K/Akt Signaling Pathways in Ca9-22 Human Oral Squamous Carcinoma Cells. |
53 | ¦X¦¨9-methoxy-6-(piperazin-1-yl)-11H-indeno[1,2-c] quinoline-11-onel¥Íª«¨Ãµû¦ô¨ä§Ü¼W¥Í¬¡©Ê-²Ä¥|³¡¤À Synthesis and antiproliferative evaluation of 9-methoxy-6-(piperazin-1-yl)-11H-indeno[1,2-c] quinoline-11-one derivatives. Part 4. |
54 | NFD ¹ï©ó¨x²ÓM¥Íªø¦]¤l»¤¾É MDA-MB-231 ²ÓMªº¾E²¾»P«Iŧ¤§§í¨î§@¥Î¡G§@¥Î¾÷¨î Inhibitory action of naphtho[1,2-b]furan-4,5-dione on hepatocyte growth factor-induced migration and invasion of MDA-MB-231 cells: Mechanisms of action |
55 | ¦X¦¨3-phenylquinolinylchalcone l¥Íª«¨Ãµû¦ô¨ä§ÜªÍÀù»P§Ü¨ÅÀù¬¡©Ê Synthesis and antiproliferative evaluation of 3-phenylquinolinylchalcone derivatives against non-small cell lung cancers and breast cancers |
56 | ¦X¦¨£]-lapachone l¥Íª«¨Ãµû¦ô¨ä§Üµoª¢¬¡©Ê Synthesis and anti-inflammatory evaluations of £]-lapachone derivatives |
57 | NFD¸g¥Ñ§í¨îEGF/EGFR¬¡¤Æ¦ÓªýÂ_¨ÅÀù²ÓMÂಾªº§@¥Î©M¾÷¨î Inhibition of EGF/EGFR activation with naphtho[1,2-b]furan-4,5-dione blocks migration and invasion of MDA-MB-231 cells |
58 | TCH-1030 targeting on topoisomerase I induces S-phase arrest, DNA fragmentation, and cell death of breast cancer cells TCH-1030 targeting on topoisomerase I induces S-phase arrest, DNA fragmentation, and cell death of breast cancer cells |
59 | ¦X¦¨Aminoalkoxy 4,5-Diphenylisoxazole §@¬°§Ü°©½è²¨ÃP¸Õ¾¯ Synthesis of Aminoalkoxy Substituted 4,5-Diphenylisoxazole Derivatives as Potential Anti-osteoporotic Agents |
60 | ±´¯ÁIndeno[1,2-c]quinolinel¥Íª«§@¬°©Ý¾ë²§ºc酶I&II§í¨î¾¯,²Ä¤T³¡¥÷ Discovery of indeno[1, 2 - c] quinoline derivatives as dual topoisomerases I/II inhibitors: part 3 |
61 | ½T»{furo[3', 2':3,4]naphtho[1,2-d]imidazole l¥Íª«¬°¤fªAmPGES-1§í¨î¾¯ Identification of furo[3', 2':3,4]naphtho[1,2-d]imidazole derivatives as orally active and selective inhibitors of microsomal prostaglandin E(2) synthase-1 (mPGES-1) |
62 | ¦X¦¨6-substituted 9-methoxy-11H-indeno[1,2-c]quinoline-11-one¬°¨ã¦³¼ç¤O¤§§ÜÀù¸Õ¾¯ Synthesis of 6-substituted 9-methoxy-11H-indeno[1,2-c]quinoline-11-one derivatives as potential anticancer agents |
63 | Combretastatin A-4l¥Íª«:¦X¦¨2,4,5-triaryl-1H-imidazoles¬°§ÜªÍÀùH1299¸Õ¾¯ Combretastatin A-4 derivatives: synthesis and evaluation of 2,4,5-triaryl-1H-imidazoles as potential agents against H1299 (non-small cell lung cancer cell) |
64 | µo²{Indeno[1,2-c]quinolinel¥Íª«¸g¥ÑRANKL§í¨î»k°©²ÓM¼W¥Í Discovery of indeno[1,2-c]quinoline derivatives as inhibitors of osteoclastogenesis induced by receptor activator of NF-£eB ligand (RANKL) |
65 | 2,3-diarylquinoline l¥Íª«¤§¦X¦¨¥H¤Î§Ü¼W¥Í¤§¬ã¨s Synthesis and antiproliferative evaluation of 2,3-diarylquinoline derivatives |
66 | 6-aryl-11-iminoindeno[1,2-c]quinoline l¥Íª«¦X¦¨»P§Ü¼W¥Í¬¡©Êµû¦ô Synthesis and antiproliferative evaluation of 6-aryl-11-iminoindeno[1,2-c]quinoline derivatives |
67 | µo²{4-anilinofuro[2,3-b]quinoline l¥Íª«¬°¤fªA§ÜªÍÀù¸Õ¾¯ Discovery of 4-anilinofuro[2,3-b]quinoline derivatives as selective and orally active compounds against non-small-cell lung cancers |
68 | Indeno[1,2-c]quinolineÃþl¥Íª«ªº¦X¦¨»P§Ü¼W¥Í¬¡©Êµû¦ô-²Ä¤G³ø Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives. Part 2 |
69 | ½T»{benzofuro[2,3-b]quinoline l¥Íª«¬°§ÜªÍµ²®Ö¸Õ¾¯ Identification of benzofuro[2,3-b]quinoline derivatives as a new class of antituberculosis agents |
70 | Furo[3',2':3,4]naphtho[1,2-d]imidazolel¥Íª«¬°±Ñ¦å¯g§Üµoª¢§í¨î¾¯ Furo[3',2':3,4]naphtho[1,2-d]imidazole derivatives as potential inhibitors of inflammatory factors in sepsis. |
71 | 3-amino-2-hydroxypropoxyisoflavonel¥Íª«ªº¦X¦¨»P§Ü°©½è²¨ÃP¬¡©Êµû¦ô Synthesis and anti-osteoporotic evaluation of certain 3-amino-2-hydroxypropoxyisoflavone derivatives |
72 | 6-arylindeno[1,2-c]quinolinel¥Íª«ªº¦X¦¨»P§Ü¼W¥Í¬¡©Êµû¦ô Synthesis and antiproliferative evaluation of 6-arylindeno[1,2-c]quinoline derivatives |
73 | indeno[1,2-c]quinoline l¥Íª«ªº¦X¦¨»P§Ü¼W¥Í¬¡©Êµû¦ô Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives |
74 | 4-anilino-8-methoxy-2-phenylquinoline »P 4-anilino-8-hydroxy-2-phenylquinolinel¥Íª«¦X¦¨¤Î§Ü¼W¥Í¬¡©Êµû¦ô Synthesis and antiproliferative evaluation of certain 4-anilino-8-methoxy-2-phenylquinoline and 4-anilino-8-hydroxy-2-phenylquinoline derivatives |
Project
NO |
YEAR ¡X Source ¡X No ¡X Type
Project Name
|
Duration |
---|---|---|
1 |
113 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST111-2320-B-037-021-MY3 ¡X 1 Ó¤H«¬
³]p¦X¦¨萘醌l¥Íª«¥Î©óªvÀø§ÜÃÄ©Ê¥Õ¦â©À¯]µß·P¬V(3/3)( )
|
2024/08/01 ~ 2025/07/31 |
2 |
112 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST111-2320-B-037-021-MY3 ¡X 1 Ó¤H«¬
³]p¦X¦¨萘醌l¥Íª«¥Î©óªvÀø§ÜÃÄ©Ê¥Õ¦â©À¯]µß·P¬V(2/3)( )
|
2023/08/01 ~ 2025/07/31 |
3 |
112 ¡X NK °ªÂå-¤¤¤s¦X§@pµe ¡X ¡X 1 Ó¤H«¬
§Q¥Î¤À¤l°ÊºA¼ÒÀÀ¸ÑªR»P¦µo©Ê©¬ª÷´Ë¤ó¯g¬ÛÃöªºPINK1³J¥Õªº¥|Ó³æÂI¬ðÅܳy¦¨PINK1¿E酶¥¢¥h¬¡©Êªºì¦](A Molecular Modeling Study on Four PINK1 Point Mutations Related to The Early Onset Parkinson¡¦s Disease)
|
2023/01/01 ~ 2023/12/31 |
4 |
112 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X NSTC112-2811-B-037-023 ¡X 9 ³Õ¤h«á¬ã¨sû
³Õ¤h¯Å¬ã¨s¤Hû--·¨²E¯ô( )
|
2023/10/01 ~ 2024/07/31 |
5 |
111 ¡X KK °ª¬ì¤j°ªÂå²£¾Ç¦X§@¸É§U ¡X ¡X
°ªÀR¤ôÀ£µ²¦XÆQ¤ôº{§ï¨}ÄJ³½¤ù¤§«~½è¤Î°§CÄJ³½¦×¹L±Ó줧À³¥Î( )
|
2022/11/01 ~ 2023/10/31 |
6 |
111 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST111-2320-B-037-021-MY3 ¡X 1 Ó¤H«¬
³]p¦X¦¨萘醌l¥Íª«¥Î©óªvÀø§ÜÃÄ©Ê¥Õ¦â©À¯]µß·P¬V(1/3)( )
|
2022/08/01 ~ 2025/07/31 |
7 |
110 ¡X KK °ª¬ì¤j°ªÂå²£¾Ç¦X§@¸É§U ¡X ¡X
¥H°ªÀR¤ôÀ£§Þ³N´£¤É¥xÆW¨©Ãþ¤§¹¥Î¦w¥þ©Ê»P¥Íª«¬¡©Ê( )
|
2021/11/05 ~ 2022/11/04 |
8 |
110 ¡X M °ªÂå(ºØ¤lpµe) ¡X KMU-M111005 ¡X
³]p»P¦X¦¨·s«¬§ÜÃÄ©Ê¥Õ¦â©À¯]µß©M¥Íª«½¤§Î¦¨ªº§í¨î¾¯( )
|
2022/01/01 ~ 2022/12/31 |
9 |
109 ¡X KI °ªÂå°ê½Ã°| ¡X KMU-KI110003 ¡X
¨u¨£¯e¯f®a±Ú©Ê¸z®§¦×¯g(FAP)¼Ð¹vÃĪ«TCH-3511¤§Non-GLPÃIJz»P¬r²z¤ÀªR( )
|
2020/08/01 ~ 2021/07/31 |
10 |
109 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST108-2320-B-037-026-MY2 ¡X 1 Ó¤H«¬
³]p¦X¦¨ÂøÀô¤Æ¦Xª«§@¬°µn²¯f¬r½Æ»sªº§í¨î¾¯(2/2)( )
|
2020/08/01 ~ 2021/07/31 |
11 |
108 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST108-2320-B-037-026-MY2 ¡X 1 Ó¤H«¬
³]p¦X¦¨ÂøÀô¤Æ¦Xª«§@¬°µn²¯f¬r½Æ»sªº§í¨î¾¯(1/2)( )
|
2019/08/01 ~ 2021/07/31 |
12 |
107 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST107-2320-B-037-015 ¡X 1 Ó¤H«¬
³]p¦X¦¨§t¦³1,2,3-¤TÐüµ²ºcªºÂøÀô¤Æ¦Xª«§@¬°§Üµn²¯f¬rÃÄ( )
|
2018/08/01 ~ 2019/07/31 |
13 |
107 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X MOST108-2813-C-037-040-B ¡X 8 ¤j±M¾Ç¥Í¬ã¨spµe
108¦~«×¤j±M¾Ç¥Í¬ã¨spµe-³¯©Ó¾§(»ùÛ3)( )
|
2019/07/01 ~ 2020/02/29 |
14 |
107 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X MOST108-2813-C-037-042-B ¡X 8 ¤j±M¾Ç¥Í¬ã¨spµe
108¦~«×¤j±M¾Ç¥Í¬ã¨spµe-¶À¨|°ó(ÃľÇ3)( )
|
2019/07/01 ~ 2020/02/29 |
15 |
106 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST106-2320-B-037-015 ¡X 1 Ó¤H«¬
³]p¦X¦¨¤TÐü喹啉¤Æ¦Xª«»PªÚ酰°ò喹³á啉¤Æ¦Xª«¨Ãµû¦ô¨ä§Üµn²¯f¬r¬¡©Ê( )
|
2017/08/01 ~ 2018/07/31 |
16 |
105 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST103-2320-B-037-011-MY3 ¡X 1 Ó¤H«¬
¦X¦¨吡Ðü°ò喹啉»PfÓi°ò喹啉Ãþl¥Íª«§@¬°§Üµn²¯f¬r¸Õ¾¯(3/3)( )
|
2016/08/01 ~ 2017/07/31 |
17 |
105 ¡X TP ³»¦ypµe(°ªÂå) ¡X KMU-TP105E16 ¡X
¤lpµe¤Q¤»¡B¦X¦¨3‐ýmÔr喹ú¿°ò°¸´ál¥Íª«§@¬°¥ÌÓi»Ä´á¥Ò°òÂಾ酶(GNMT)ªí²{¤§½Õ±±¾¯( )
|
2016/11/01 ~ 2017/10/31 |
18 |
105 ¡X TP ³»¦ypµe(°ªÂå) ¡X KMU-TP105H08 ¡X
¤lpµe¤K¡B¦X¦¨ªÚ»Àô°¸´áÃþl¥Íª«¨Ã¨ä§Üµn²¯f¬r¬¡©Ê( )
|
2016/11/01 ~ 2017/10/31 |
19 |
104 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST103-2320-B-037-011-MY3 ¡X 1 Ó¤H«¬
¦X¦¨吡Ðü°ò喹啉»PfÓi°ò喹啉Ãþl¥Íª«§@¬°§Üµn²¯f¬r¸Õ¾¯(2/3)( )
|
2015/08/01 ~ 2017/07/31 |
20 |
104 ¡X TP ³»¦ypµe(°ªÂå) ¡X KMU-TP104E16 ¡X
¤lpµe¤Q¤»¡B±´¯Á·s«¬f°ò°¸´ál¥Íª«§@¬°½Õ±±苷Ói»Ä´á¥Ò°òÂಾ酶(GNMT)ªí²{¥HªvÀø¨xÀù( )
|
2015/10/01 ~ 2016/09/30 |
21 |
104 ¡X TP ³»¦ypµe(°ªÂå) ¡X KMU-TP104H08 ¡X
¤lpµe¤K¡B¦X¦¨ªÚ»Àô°¸´áÃþl¥Íª«¨Ãµû¦ô¨ä§Üµn²¯f¬r¬¡©Ê( )
|
2015/10/01 ~ 2016/09/30 |
22 |
103 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST103-2320-B-037-011-MY3 ¡X 1 Ó¤H«¬
¦X¦¨吡Ðü°ò喹啉»PfÓi°ò喹啉Ãþl¥Íª«§@¬°§Üµn²¯f¬r¸Õ¾¯(1/3)( )
|
2014/08/01 ~ 2017/07/31 |
23 |
103 ¡X Q ·s¸u±Ð®vpµe(®Õ¤º) ¡X KMU-Q104016 ¡X
¦X¦¨茚[1,2-b]喹³á¥ðÃþl¥Íª«§@¬°§Ü¸~½FÃĪ«( )
|
2015/01/01 ~ 2015/12/31 |
24 |
103 ¡X TP ³»¦ypµe(°ªÂå) ¡X KMU-TP103H08 ¡X
¬ãµo¨ã¦³§Üµn²¼ö¼ç¯à¤§喹ú¿Ãþl¥Íª«( )
|
2014/08/01 ~ 2015/07/31 |
25 |
102 ¡X Q ·s¸u±Ð®vpµe(®Õ¤º) ¡X KMU-Q103028 ¡X
µv°ò呋³ä¤A²m茚[1,2-c]喹啉»Pµv°ò呋³ä¤A²m喹啉Ãþ¤Æ¦Xª«¤§¦X¦¨¤Î¥Íª«¬¡©Êµû¦ô( )
|
2014/01/01 ~ 2014/12/31 |
26 |
101 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC102-2320-B-037-001 ¡X 1 Ó¤H«¬
2-ªÚ酰°ò-3-ªÚ»Àô喹啉Ãþ¤Æ¦Xª«»P2-ªÚ酰°ò-4-fÓi°òÃþ¤Æ¦Xª«¤§¦X¦¨¤Î§Üµn²¯f¬r¬¡©Êµû¦ô( )
|
2013/05/01 ~ 2014/07/31 |
Patent
NO | Patent Name | Country | Certified Date | Patent No |
---|---|---|---|---|
1 | 7, 3¡¦, 4¡¦-¤j¨§²§¶À଻s¾¯ªº»s³Æ¤èªk | ¤¤µØ¥Á°ê | 2017/05/21 | I583404 |
2 | ¨ã§í¨î²Óµß¸²µåÁÞîÇ»Ä?¬¡©Ê¤§?Ðü¨Ã [4¡A3-c] ??l¥Íª« | ¤¤µØ¥Á°ê | 2018/02/11 | I614251 |
3 | ?Ðü°ò??¤Æ¦Xª«¤Î¨ä»s³Æ¤èªk»PÂåÃIJզ¨ª« | ¤¤µØ¥Á°ê | 2018/04/01 | I619708 |
4 | ¨ã§í¨î²Óµß¸²µåÁÞîÇ»Ä?¬¡©Ê¤§?Ðü¨Ã [4¡A3-c] ??l¥Íª« | ¥@¬É±M§Q(¤¤°ê) | 2021/08/27 | 4641308 |
5 | ¨ã§í¨î²Óµß¸²µåÁÞîÇ»Ä?¬¡©Ê¤§?Ðü¨Ã[4¡A3-c]??l¥Íª«(¼w¡B^¡Bªk) | ¥@¬É±M§Q(¼Ú·ù) | 2020/02/12 | 3302060 |
6 | ¨ã§í¨î²Óµß¸²µåÁÞîÇ»Ä?¬¡©Ê¤§?Ðü¨Ã [4¡A3-c] ??l¥Íª« | ¥@¬É±M§Q(¬ü°ê) | 2021/10/05 | 11,135,206 |
7 | ¨ã§í¨î²Óµß¸²µåÁÞîÇ»Ä?¬¡©Ê¤§?Ðü¨Ã [4¡A3-c] ??l¥Íª« | ¥@¬É±M§Q(¤é¥») | 2019/11/01 | 6607962 |
8 | ¶Ý¤¤©Ê¥Õ¦å²yµoª¢§í¨î¾¯¤Î¨ä¥Î³~ | ¤¤µØ¥Á°ê | 2020/01/01 | I680973 |
9 | ¶Ý¤¤©Ê¥Õ¦å²yµoª¢§í¨î¾¯¤Î¨äÀ³¥Î | ¬ü°ê | 2020/05/19 | 10,654,848 |
10 | ?Ðü°ò??¤Æ¦Xª«¤Î¨ä»s³Æ¤èªk»PÂåÃIJզ¨ª« | ¥@¬É±M§Q(·s¥[©Y) | 2020/03/23 | 11201900865P |
11 | ?Ðü°ò??l¥Íª«¡A¨ä»s³Æ¤èªk¥H¤Î¥]§t¦³¦¹µ¥l¥Íª«ªºÃľDzզ¨ª« | ¥@¬É±M§Q(¤¤°ê) | 2022/10/11 | 5501385 |
12 | ¨ã§í¨î²Óµß¸²µåÁÞîÇ»Ä?¬¡©Ê¤§?Ðü¨Ã[4¡A3-c]??l¥Íª« | ¥@¬É±M§Q(¬ü°ê) | 2021/07/06 | 11,052,072 |
13 | ¨ã§í¨î²Óµß¸²µåÁÞîÇ»Ä?¬¡©Ê¤§?Ðü¨Ã[4¡A3-c]??l¥Íª« | ¥@¬É±M§Q(¼Ú·ù) | 2021/10/13 | 3662751 |
14 | ¨ã§í¨î²Óµß¸²µåÁÞîÇ»Ä?¬¡©Ê¤§?Ðü¨Ã [4¡A3-c] ??l¥Íª« | ¥@¬É±M§Q(¤¤°ê) | 2021/10/26 | 4751135 |
15 | ¥ÌÓi»ÄN-¥Ò°òÂಾ?¼W±j¾¯¡B¨ä»s³Æ¤èªk¤Î¨ä¥Î³~ | ¤¤µØ¥Á°ê | 2022/03/01 | I757011 |
16 | ¶Ý¤¤©Ê¥Õ¦å²yµoª¢§í¨î¾¯¤Î¨äÀ³¥Î | ¥@¬É±M§Q(¼Ú·ù) | 2023/09/13 | 3876933 |
17 | ¥ÌÓi»ÄN-¥Ò°òÂಾ?¼W±j¾¯¡B¨ä»s³Æ¤èªk¤Î¨ä¥Î³~ | ¥@¬É±M§Q(¤¤°ê) | 2024/04/19 | 6928457 |